{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:01:38Z","timestamp":1778943698973,"version":"3.51.4"},"reference-count":12,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,6,26]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Acquired C1-inhibitor (C1-INH) deficiency is a rare and potentially life-threatening disorder, which presents with recurrent attacks of non-pitting oedema to the face, airway, limbs or gastrointestinal tract. It is often associated with underlying B-cell lymphoproliferative disorders. We describe a case of a 73-year-old man with acquired C1-INH deficiency who presented with nephrotic syndrome due to glomerular IgM deposition, secondary to an underlying secretory lymphoplasmacytic lymphoma. Both the acquired C1-INH deficiency and the nephrotic syndrome resolved when the underlying B-cell lymphoma was treated with rituximab and bendamustine, suggesting the underlying lymphoproliferative malignancy was driving both disorders.<\/jats:p>","DOI":"10.1136\/bcr-2019-230388","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T05:35:15Z","timestamp":1562909715000},"page":"e230388","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Acquired C1-inhibitor deficiency presenting with nephrotic syndrome"],"prefix":"10.1136","volume":"12","author":[{"given":"Jamie","family":"Willows","sequence":"first","affiliation":[{"name":"Renal Services, Freeman Hospital, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Wood","sequence":"additional","affiliation":[{"name":"Histopathology Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Bourne","sequence":"additional","affiliation":[{"name":"Immunology Department, Freeman Hospital, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Andrew","family":"Sayer","sequence":"additional","affiliation":[{"name":"Renal Services, Freeman Hospital, Newcastle upon Tyne, UK"},{"name":"Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"2025082700502200000_12.7.e230388.1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1752-1947-2-328","article-title":"Membranous nephropathy in a patient with hereditary angioedema: a case report","volume":"2","author":"Smith","year":"2008","journal-title":"J Med Case Reports"},{"key":"2025082700502200000_12.7.e230388.2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12159"},{"key":"2025082700502200000_12.7.e230388.3","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-6-14"},{"key":"2025082700502200000_12.7.e230388.4","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(72)90006-2"},{"key":"2025082700502200000_12.7.e230388.5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2500\/aap.2009.30.3188","article-title":"The spectrum of chronic angioedema","volume":"30","author":"Banerji","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"2025082700502200000_12.7.e230388.6","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine"},{"key":"2025082700502200000_12.7.e230388.7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaip.2016.12.032","article-title":"Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency","volume":"5","author":"Zanichelli","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025082700502200000_12.7.e230388.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02686.x"},{"key":"2025082700502200000_12.7.e230388.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.05.003"},{"key":"2025082700502200000_12.7.e230388.10","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"Am J Med"},{"key":"2025082700502200000_12.7.e230388.11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7 patients treated with rituximab","volume":"32","author":"Branellec","year":"2012","journal-title":"J Clin Immunol"},{"key":"2025082700502200000_12.7.e230388.12","doi-asserted-by":"publisher","DOI":"10.1177\/0897190014546101"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:50:30Z","timestamp":1756281030000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,11]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bcr-2019-230388"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230388","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}